Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

India’s Vivimed Buys Chemical Maker Uquifa

by Rick Mullin
December 12, 2011 | A version of this story appeared in Volume 89, Issue 50

Vivimed Labs, an Indian health care and cosmetics firm, has acquired Uquifa, a producer of active pharmaceutical ingredients (APIs) and finished-dosage drugs based in Barcelona for a reported $55 million. Uquifa, which also has operations in Mexico, will become the API division of Vivimed. The firm says it will invest in Uquifa R&D and manufacturing facilities in India. Vivimed purchased James Robinson, a British dyes and photochromics company, in 2008.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.